tiprankstipranks
Trending News
More News >
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC
US Market
Advertisement

China SXT Pharmaceuticals (SXTC) Ratios

Compare
273 Followers

China SXT Pharmaceuticals Ratios

SXTC's free cash flow for Q4 2024 was $0.27. For the 2024 fiscal year, SXTC's free cash flow was decreased by $ and operating cash flow was $7.34. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
1.60 1.35 1.31 1.25 1.60
Quick Ratio
1.51 1.31 1.25 1.20 1.53
Cash Ratio
1.36 1.20 0.91 0.72 0.59
Solvency Ratio
0.73 -0.38 -0.32 -0.13 -0.81
Operating Cash Flow Ratio
-0.15 >-0.01 0.02 -0.07 0.08
Short-Term Operating Cash Flow Coverage
-0.59 -0.02 0.13 -35.47 0.14
Net Current Asset Value
$ 5.04M$ 4.66M$ 5.33M$ 4.65M$ 7.34M
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.13 0.06 <0.01 0.31
Debt-to-Equity Ratio
0.19 0.26 0.12 <0.01 0.72
Debt-to-Capital Ratio
0.16 0.20 0.11 <0.01 0.42
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 0.00 <0.01 <0.01
Financial Leverage Ratio
1.66 2.01 2.04 2.16 2.31
Debt Service Coverage Ratio
3.11 -1.49 -2.38 -1.00 -0.09
Interest Coverage Ratio
0.00 -11.76 -23.78 -1.36 1.28
Debt to Market Cap
0.01 1.82 0.35 <0.01 0.49
Interest Debt Per Share
2.15 15.86 54.45 57.64 814.68
Net Debt to EBITDA
-1.28 2.61 2.67 7.18 0.56
Profitability Margins
Gross Profit Margin
26.86%21.62%48.10%59.43%52.37%
EBIT Margin
733.81%-276.82%-206.41%-45.99%-25.98%
EBITDA Margin
743.97%-264.13%-194.11%-38.76%-19.55%
Operating Profit Margin
691.04%-284.40%-199.43%-45.99%83.00%
Pretax Profit Margin
667.16%-301.00%-207.82%-61.56%-201.26%
Net Profit Margin
667.16%-301.00%-220.43%-57.52%-199.29%
Continuous Operations Profit Margin
667.16%-301.00%-220.43%-57.52%-199.29%
Net Income Per EBT
100.00%100.00%106.07%93.45%99.02%
EBT Per EBIT
96.54%105.84%104.21%133.85%-242.48%
Return on Assets (ROA)
28.53%-20.08%-17.10%-7.95%-47.40%
Return on Equity (ROE)
47.36%-40.40%-34.92%-17.22%-109.43%
Return on Capital Employed (ROCE)
48.04%-37.24%-31.60%-13.76%45.40%
Return on Invested Capital (ROIC)
39.90%-32.84%-29.80%-12.83%26.31%
Return on Tangible Assets
28.55%-20.10%-17.12%-7.97%-47.51%
Earnings Yield
320.70%-313.54%-98.51%-10.38%-74.28%
Efficiency Ratios
Receivables Turnover
0.75 1.47 0.53 0.62 0.48
Payables Turnover
0.57 1.12 0.91 1.33 1.27
Inventory Turnover
0.91 2.91 1.33 2.25 2.75
Fixed Asset Turnover
1.75 1.55 1.64 2.67 2.71
Asset Turnover
0.04 0.07 0.08 0.14 0.24
Working Capital Turnover Ratio
0.19 0.38 0.52 0.79 0.62
Cash Conversion Cycle
240.69 48.96 563.70 480.99 597.19
Days of Sales Outstanding
485.27 248.91 689.27 593.38 752.83
Days of Inventory Outstanding
401.12 125.47 274.98 161.91 132.54
Days of Payables Outstanding
645.70 325.43 400.55 274.30 288.18
Operating Cycle
886.39 374.38 964.25 755.29 885.37
Cash Flow Ratios
Operating Cash Flow Per Share
-1.09 -0.30 6.45 -45.74 75.56
Free Cash Flow Per Share
-1.10 -0.57 4.95 -48.98 42.67
CapEx Per Share
<0.01 0.26 1.50 3.23 32.89
Free Cash Flow to Operating Cash Flow
1.01 1.88 0.77 1.07 0.56
Dividend Paid and CapEx Coverage Ratio
-190.90 -1.14 4.29 -14.15 2.30
Capital Expenditure Coverage Ratio
-190.90 -1.14 4.29 -14.15 2.30
Operating Cash Flow Coverage Ratio
-0.51 -0.02 0.13 -30.33 0.14
Operating Cash Flow to Sales Ratio
-1.36 -0.04 0.10 -0.28 0.18
Free Cash Flow Yield
-0.70%-8.00%3.53%-5.32%3.81%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
0.31 -0.32 -1.02 -9.64 -1.35
Price-to-Sales (P/S) Ratio
194.77 0.96 2.24 5.54 2.68
Price-to-Book (P/B) Ratio
0.15 0.13 0.35 1.66 1.47
Price-to-Free Cash Flow (P/FCF) Ratio
-142.09 -12.50 28.29 -18.79 26.25
Price-to-Operating Cash Flow Ratio
-1.52 -23.44 21.70 -20.11 14.82
Price-to-Earnings Growth (PEG) Ratio
<0.01 <0.01 -0.02 0.11 <0.01
Price-to-Fair Value
0.15 0.13 0.35 1.66 1.47
Enterprise Value Multiple
24.90 2.25 1.52 -7.12 -13.16
Enterprise Value
184.11M -11.72M -7.66M 13.19M 13.29M
EV to EBITDA
25.02 2.25 1.52 -7.12 -13.16
EV to Sales
186.18 -5.94 -2.94 2.76 2.57
EV to Free Cash Flow
-135.82 77.38 -37.20 -9.36 25.18
EV to Operating Cash Flow
-136.53 145.11 -28.53 -10.02 14.22
Tangible Book Value Per Share
11.28 54.92 393.98 552.97 756.33
Shareholders’ Equity Per Share
11.29 55.03 394.91 554.56 760.38
Tax and Other Ratios
Effective Tax Rate
0.03 -0.08 -0.06 0.07 <0.01
Revenue Per Share
0.80 7.39 62.57 165.99 417.52
Net Income Per Share
5.35 -22.23 -137.92 -95.48 -832.08
Tax Burden
1.00 1.00 1.06 0.93 0.99
Interest Burden
0.91 1.09 1.01 1.34 7.75
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
7.33 2.86 2.12 0.72 0.48
Stock-Based Compensation to Revenue
0.36 0.28 0.90 0.00 0.00
Income Quality
-0.20 0.01 -0.05 0.48 -0.09
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis